Rockwell Medical Profitable on Cash Flow Adj,usted EBITDA, Ups Guidance
- Reports net sales of $25.8 million for the second quarter of 2024, an increase of 43% over the same period in 2023.
- Reports gross profit of $4.6 million for the second quarter of 2024, an increase of 341% over the same period in 2023.
- Achieves gross margin of 18% for the second quarter of 2024 compared to a gross margin of 6% for the same period in 2023.
- Generates $1.4 million in cash flow from operations for the second quarter of 2024.
- Expects net sales for 2024 to range between $95 million and $98 million, raising guidance for the second time this year.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.